Vidac Pharma Holding (STU:T9G) OCF Margin %: 0.00% (As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:T9G Vidac Pharma Holding PLC STU:T9G
21 GF Score
Price €0.42
! 2 Warning Signs
View Full Analysis

What is Vidac Pharma Holding OCF Margin %?

Vidac Pharma Holding STU:T9G +1.94% 21 OCF Margin % is 0.00% as of Jun. 2025. GuruFocus rates STU:T9G with a GF Score™ of 21/100. The stock has 2 warning signs investors should review. Among 954 Biotechnology companies, Vidac Pharma Holding ranks worse than 104821.7% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Vidac Pharma Holding's Cash Flow from Operations for the six months ended in Jun. 2025 was €-0.75 Mil. Vidac Pharma Holding's Revenue for the six months ended in Jun. 2025 was €0.00 Mil. Therefore, Vidac Pharma Holding's OCF Margin % for the quarter that ended in Jun. 2025 was 0.00%.

As of today, Vidac Pharma Holding's current OCF Yield % is -5.07%.

The historical rank and industry rank for Vidac Pharma Holding's OCF Margin % or its related term are showing as below:


STU:T9G's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -65.67
* Ranked among companies with meaningful OCF Margin % only.

Vidac Pharma Holding OCF Margin % Related Terms

Vidac Pharma Holding OCF Margin % Historical Data

* Premium members only.

The historical data trend for Vidac Pharma Holding's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vidac Pharma Holding OCF Margin % Chart

Vidac Pharma Holding Annual Data
Trend Dec21 Dec22 Dec23 Dec24
OCF Margin %
0.00 0.00 0.00 0.00

Vidac Pharma Holding Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
OCF Margin % Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
STU:T9G
21GF Score
Vidac Pharma Holding PLC STU:T9G
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vidac Pharma Holding OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Vidac Pharma Holding's OCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-0.896/0
= %

Vidac Pharma Holding's OCF Margin for the quarter that ended in Jun. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Jun. 2025 )/Revenue (Q: Jun. 2025 )
=-0.745/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Vidac Pharma Holding (STU:T9G) has a OCF Margin % of 0.00% as of Jun. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Vidac Pharma Holding and its competitors. According to the industry distribution chart, Vidac Pharma Holding ranks #999999 out of 954 companies in the Biotechnology industry.
Is Vidac Pharma Holding's OCF Margin % too high?
Vidac Pharma Holding's current OCF Margin % is 0.00%. Based on the distribution chart, Vidac Pharma Holding ranks #999999 out of 954 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Vidac Pharma Holding has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Vidac Pharma Holding's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Vidac Pharma Holding ranks #999999 out of 954 companies for OCF Margin %. This places Vidac Pharma Holding in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Vidac Pharma Holding and its competitors. Vidac Pharma Holding's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vidac Pharma Holding stock overvalued right now?
Vidac Pharma Holding (STU:T9G) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Vidac Pharma Holding's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Vidac Pharma Holding (STU:T9G), the current OCF Margin % is 0.00% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vidac Pharma Holding Business Description

Other Exchanges T9G:Germany
Address 20-22 Wenlock Road, London, GBR, N1 7GU
Vidac Pharma Holding PLC is a clinical-stage biopharmaceutical company that focuses on discovering and developing medicines for oncologic and onco-dermatologic diseases. The company's research targets the modification of the tumor microenvironment to inhibit cancer cell growth by selectively affecting metabolic checkpoints in cancer cells without harming normal tissue. Its drug pipeline includes candidates such as VDA-1102 ointment, VDA-1102 IV, and VDA-1275, which are designed to treat conditions like Actinic Keratosis and Cutaneous T-cell Lymphoma. Vidac Pharma operates internationally with headquarters in London and aims to treat cancer through novel chemical entities.
21GF Score

Get the complete analysis for STU:T9G

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.42
Price